A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection.
CRISPR-Cas Systems
Humans
Interferon Regulatory Factor-2
/ metabolism
Endoribonucleases
/ metabolism
2',5'-Oligoadenylate Synthetase
/ metabolism
RNA Stability
Virus Diseases
/ genetics
Gene Knockout Techniques
RNA, Viral
/ genetics
HEK293 Cells
Virus Replication
/ genetics
STAT2 Transcription Factor
/ metabolism
CRISPR screen
RNA decay
RNase L
innate immunity
virus
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
05 Nov 2024
05 Nov 2024
Historique:
medline:
31
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
ppublish
Résumé
OAS-RNase L is a double-stranded RNA-induced antiviral pathway triggered in response to diverse viral infections. Upon activation, OAS-RNase L suppresses virus replication by promoting the decay of host and viral RNAs and inducing translational shutdown. However, whether OASs and RNase L are the only factors involved in this pathway remains unclear. Here, we develop CRISPR-Translate, a FACS-based genome-wide CRISPR-Cas9 knockout screening method that uses translation levels as a readout and identifies IRF2 as a key regulator of OAS3. Mechanistically, we demonstrate that IRF2 promotes basal expression of OAS3 in unstressed cells, allowing a rapid activation of RNase L following viral infection. Furthermore, IRF2 works in concert with the interferon response through STAT2 to further enhance OAS3 expression. We propose that IRF2-induced RNase L is critical in enabling cells to mount a rapid antiviral response immediately after viral infection, serving as the initial line of defense. This rapid response provides host cells the necessary time to activate additional antiviral signaling pathways, forming secondary defense waves.
Identifiants
pubmed: 39475651
doi: 10.1073/pnas.2412725121
doi:
Substances chimiques
2-5A-dependent ribonuclease
EC 3.1.26.-
Interferon Regulatory Factor-2
0
Endoribonucleases
EC 3.1.-
2',5'-Oligoadenylate Synthetase
EC 2.7.7.84
IRF2 protein, human
0
OAS3 protein, human
EC 2.7.7.84
RNA, Viral
0
STAT2 Transcription Factor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2412725121Subventions
Organisme : HHS | National Institutes of Health (NIH)
ID : R37-CA252081
Organisme : HHS | National Institutes of Health (NIH)
ID : R01-AI155962
Organisme : American Cancer Society (ACS)
ID : RSG-24-1249960-01-DMC
Déclaration de conflit d'intérêts
Competing interests statement:The authors declare no competing interest.